Join our community
Receive insights and exclusive offers on peptide wellness.
Retatrutide (LY3437943) is a novel peptide in development, not yet available as a common brand-name drug like Semaglutide (Wegovy/Ozempic) or Tirzepatide (Mounjaro/Zepbound); however, research-grade versions are sold.